Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
Promotional pricing Brello frequently runs promotions
Administer Dose & Hold: Press and hold down the dose button until it reaches 0
However, eligibility depends on your overall health status, disease control (particularly diabetes stability), absence of active side effects, and individual donation center policies
Use official donor-center guidance for the final answer before scheduling
It is appropriate for adults with a BMI of 30 or higher, or 27 and above,particularly those who also experience weight-related health conditions like high blood pressure or type 2 diabetes.Most people begin to notice results within the first few weeks of treatment, with significant weight loss often occurring within two to three months